By targeting share repurchases, capital discipline is recast as profiteering, raising risks to supply, margins, and ...

Initiation of Coverage with $4.50 Per Share Valuation Zacks initiated coverage on Cosmos Health and assigned a $4.50 per share valuation based on a discounted cash flow (DCF) analysis, reflecting ...

As of December 31, 2025, NioCorp had a record consolidated cash balance of $307 million. I believe this fundraising success has also significantly strengthened EXIM's confidence in our ability to ...

Eikon Therapeutics, Inc. eyes IPO to fund EIK1001 oncology pipeline; early Phase 2 data show 60% response rate. Click for ...

So while Thill recommended that investors "stay underweight" the sector this year, he flagged some notable exceptions. His top picks in the software universe include some big names like Microsoft ...

Ultragenyx Pharmaceutical (RARE) remains a Sell after its Phase 3 OI program failed to meet primary fracture reduction endpoints, eroding its key ...

As many market participants anticipate a year-end rally, there are mounting indications that such an outcome is far from assured. Investor positioning appears increasingly stretched, with multiple ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Ally Financial's board has ...

Shares of W.R. Berkley Corp. WRB slid 1.09% to $70.87 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.11% to 6,857.12 and ...

Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

A day after Thursday’s anxiety-inducing fake out, Friday turned into Redemption Day on Wall Street. The Dow ended the day 493 points higher, or 1.08%, after gaining as much as 800 points earlier in ...

WASHINGTON— A week before he voted to significantly cut Medicaid, Rep. Rob Bresnahan dumped six figures’ worth of stock in a quartet of companies that manage nearly half of all Medicaid enrollees in ...